American Society of Plastic Surgeons logo
Connecticut OFFICE

2 Greenwich Office Park
Suite 210
Greenwich, CT 06831
203 863-0003

Greenwich Hospital Office

77 Lafayette Place
Suite 302
Greenwich, CT 06830
203 863-0003

Dutchess County Office

21 Reade Place

Suite 2100
Poughkeepsie, NY 12601
203 863-0003

Bronx Office

2425 Eastchester Road
Bronx, NY 10469

News

Tamoxifen Plus Radiation With DCIS Lumpectomy Lowers Cancer Recurrence Risk

Posted Date: March 16, 2011

For women with ductal carcinoma in situ (DCIS), adding radiation therapy and/or tamoxifen to treatment lowers the risk of the recurrence of aggressive cancer, doctors at Allegheny General Hospital and the National Surgical Adjuvant Breast Bowel Project revealed in the Journal of the National Cancer Institute.

For women with ductal carcinoma in situ (DCIS), adding radiation therapy and/or tamoxifen to treatment lowers the risk of the recurrence of aggressive cancer, doctors at Allegheny General Hospital and the National Surgical Adjuvant Breast Bowel Project revealed in the Journal of the National Cancer Institute.

Female participants with DCIS were followed for between 13.5 to 17 years in two previous NSABP trials. Breast tumor recurrence in the previously affected breast went down 52% in those who received a lumpectomy combined with radiotherapy, compared to those who only had the surgery. When tamoxifen was also added to the treatment of patients with estrogen receptor positive DCIS, breast tumor recurrence in the previously affected breast   risk fell 32% compared to those who had a lumpectomy and radiotherapy only.

>> Read more: Journal of the National Cancer Institute

 

PLEASE ENTER YOUR PORTAL LOGIN


CANCEL